{"id":483122,"date":"2021-04-28T07:33:17","date_gmt":"2021-04-28T11:33:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/"},"modified":"2021-04-28T07:33:17","modified_gmt":"2021-04-28T11:33:17","slug":"translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/","title":{"rendered":"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">LEXINGTON, Mass., April  28, 2021  (GLOBE NEWSWIRE) &#8212; Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today announced that Ronald Renaud, chief executive officer, will participate in a fireside chat at the 7th Annual Truist Securities Life Sciences Summit on May 5, 2021 at 10:30 a.m. EST.<\/p>\n<p>A live webcast of the session will be accessible through the \u201cEvents and Presentations\u201d page of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mgFGVovUAHw-2ZR60Q5rLTWXL3VJXbEHtPtyFUuvMgW_KQGTs5wJjxEXUKxw2vvXm33Vee6Gx8reQYsoMeDJzugdoym7uJZLWaZR9agO3tQcbtRHLaL-LKPUT4zKj7aaYH-vE_yeSg7jR0-6EuFe6YrdNNtlC--q8xJuSGKXEGqwxdyQu1naQdlt4NC7Blod\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.translate.bio\/investors\/news-and-events<\/a>. A replay of the webcasts will be archived on the Translate Bio\u2019s website for 30 days following the presentation.<\/p>\n<p>\n        <strong>About Translate Bio<\/strong><br \/>\n        <br \/>Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, or to prevent infectious diseases by generating protective immunity. Translate Bio is primarily focused on applying its technology to treat pulmonary diseases with a lead pulmonary candidate being evaluated as an inhaled treatment for cystic fibrosis (CF) in a Phase 1\/2 clinical trial. Additional pulmonary diseases are being evaluated in discovery-stage research programs that utilize a proprietary lung delivery platform. Translate Bio also believes its technology may apply broadly to a wide range of diseases, including diseases that affect the liver. Additionally, the platform may be applied to various classes of treatments, such as therapeutic antibodies or protein degradation. Translate Bio is also pursuing the development of mRNA vaccines for infectious diseases under a collaboration with Sanofi Pasteur. For more information about the Company, please visit www.translate.bio or on Twitter at @TranslateBio.<\/p>\n<p>\n        <strong>Contacts for Translate Bio<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:934px;border-collapse:collapse\">\n<tr>\n<td>\n            <strong>Investor<\/strong>\n          <\/td>\n<td>\n            <strong>Media<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Teri Dahlman\u00a0\u00a0<\/td>\n<td>Maura Gavaghan<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:tdahlman@translate.bio\" rel=\"nofollow noopener\" target=\"_blank\">tdahlman@translate.bio<\/a>\n          <\/td>\n<td>\n            <a href=\"mailto:mgavaghan@translate.bio\" rel=\"nofollow noopener\" target=\"_blank\">mgavaghan@translate.bio<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td>617-817-8655<\/td>\n<td>617-233-1154<\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/463233cc-63e9-4d23-a67b-d02946d66957\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today announced that Ronald Renaud, chief executive officer, will participate in a fireside chat at the 7th Annual Truist Securities Life Sciences Summit on May 5, 2021 at 10:30 a.m. EST. A live webcast of the session will be accessible through the \u201cEvents and Presentations\u201d page of the Company&#8217;s website at https:\/\/investors.translate.bio\/investors\/news-and-events. A replay of the webcasts will be archived on the Translate Bio\u2019s website for 30 days following the presentation. About Translate Bio Translate Bio is a clinical-stage mRNA therapeutics company developing a new &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-483122","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today announced that Ronald Renaud, chief executive officer, will participate in a fireside chat at the 7th Annual Truist Securities Life Sciences Summit on May 5, 2021 at 10:30 a.m. EST. A live webcast of the session will be accessible through the \u201cEvents and Presentations\u201d page of the Company&#8217;s website at https:\/\/investors.translate.bio\/investors\/news-and-events. A replay of the webcasts will be archived on the Translate Bio\u2019s website for 30 days following the presentation. About Translate Bio Translate Bio is a clinical-stage mRNA therapeutics company developing a new &hellip; Continue reading &quot;Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T11:33:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit\",\"datePublished\":\"2021-04-28T11:33:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/\"},\"wordCount\":301,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/\",\"name\":\"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=\",\"datePublished\":\"2021-04-28T11:33:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/","og_locale":"en_US","og_type":"article","og_title":"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk","og_description":"LEXINGTON, Mass., April 28, 2021 (GLOBE NEWSWIRE) &#8212; Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today announced that Ronald Renaud, chief executive officer, will participate in a fireside chat at the 7th Annual Truist Securities Life Sciences Summit on May 5, 2021 at 10:30 a.m. EST. A live webcast of the session will be accessible through the \u201cEvents and Presentations\u201d page of the Company&#8217;s website at https:\/\/investors.translate.bio\/investors\/news-and-events. A replay of the webcasts will be archived on the Translate Bio\u2019s website for 30 days following the presentation. About Translate Bio Translate Bio is a clinical-stage mRNA therapeutics company developing a new &hellip; Continue reading \"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-28T11:33:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit","datePublished":"2021-04-28T11:33:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/"},"wordCount":301,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/","name":"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=","datePublished":"2021-04-28T11:33:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNDk3NSM0MTQyNjk5IzIxMTA0OTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/translate-bio-to-present-at-the-7th-annual-truist-securities-life-sciences-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=483122"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483122\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=483122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=483122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=483122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}